Regeneron Pharmaceuticals, Inc. (REGN) financial statements (2020 and earlier)

Company profile

Business Address 777 OLD SAW MILL RIVER ROAD
TARRYTOWN, NY 10591
State of Incorp. NY
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments3,2142,8101,4101,0391,045900694
Cash and cash equivalents1,6181,468813535809649536
Short-term investments1,5971,342597503236252158
Receivables2,3611,9501,7321,4361,306739892
Inventory, net of allowances, customer advances and progress billings1,4161,15172639923912970
Inventory1,4161,15172639923912970
Deferred tax assets    4945
Other undisclosed current assets69953646730632635096
Total current assets:7,6896,4484,3353,1802,9152,1671,797
Noncurrent Assets
Property, plant and equipment2,8902,5762,3592,0831,594974527
Long-term investments and receivables3,2571,7551,486864632460390
Long-term investments3,2571,7551,486864632460390
Deferred income tax assets824
Other noncurrent assets1451277820635
Deferred tax assets, net 506825462267232
Other undisclosed noncurrent assets 829     
Total noncurrent assets:7,1165,2874,4293,7932,6941,7041,154
TOTAL ASSETS:14,80511,7358,7646,9735,6093,8722,951
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:1,087772815879644484251
Accounts payable 218178135141  
Accrued liabilities30116512910486  
Employee-related liabilities3442621921531339369
Taxes payable49210236   
Other undisclosed accounts payable and accrued liabilities392107315252284391181
Deferred revenue592
Debt   127  0
Deferred revenue and credits3202321537447
Contract with customer, liability453
Other liabilities  031496 
Other undisclosed current liabilities418218    1
Total current liabilities:2,0971,4431,1351,241811655299
Noncurrent Liabilities
Long-term debt and lease obligation714    147320
Long-term debt, excluding current maturities     147320
Finance lease, liability714
Liabilities, other than long-term debt905826781931780217196
Deferred revenue and credits629831665176184
Deferred revenue619
Contract with customer, liability464
Other liabilities2863621521001164111
Other undisclosed noncurrent liabilities 709703352363311184
Total noncurrent liabilities:1,6191,5341,4851,2831,143675700
Total liabilities:3,7162,9772,6202,5241,9541,330999
Stockholders' equity
Stockholders' equity attributable to parent, including:11,0908,7576,1444,4493,6552,5421,952
Treasury stock, value(740)(396)(316)(316)(306)170 
Additional paid in capital4,4293,9123,5133,0303,1002,4042,046
Accumulated other comprehensive income (loss)21(12)1(13)952(1)
Retained earnings (accumulated deficit)7,3805,2542,9471,748853255(93)
Receivable from shareholders or affiliates for issuance of capital stock      (1)
Other undisclosed stockholders' equity attributable to parent00000(339)1
Total stockholders' equity:11,0908,7576,1444,4493,6552,5421,952
TOTAL LIABILITIES AND EQUITY:14,80511,7358,7646,9735,6093,8722,951

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues7,8636,7115,8724,8604,1042,8202,105
Revenue, net4,9344,1163,5232,3241,884
Cost of revenue(768)(434)(397)(300)(393)(205)(155)
Cost of goods and services sold(74) (203)(209)(252)(135)(127)
Gross profit:7,0966,2775,4754,5613,7112,6151,950
Operating expenses(4,886)(3,742)(3,396)(3,230)(2,459)(1,776)(1,190)
Operating income:2,2102,5342,0801,3311,252838760
Nonoperating income (expense)21919(1)(1)(27)(63)(47)
Other nonoperating income2504724668 
Interest and debt expense(30)(28)  (19)(71)(46)
Other undisclosed income from continuing operations before equity method investments, income taxes3028  197146
Income from continuing operations before income taxes:2,4292,5542,0791,3301,225776713
Income tax expense(313)(109)(880)(434)(589)(428)(289)
Net income available to common stockholders, basic:2,1162,4441,199896636348424
Interest on convertible debt   0   
Net income available to common stockholders, diluted:2,1162,4441,199896636348424

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net income:2,1162,4441,199896636348424
Other comprehensive income (loss) (6)13(3)(25)  
Comprehensive income:2,1162,4381,212892611348424
Other undisclosed comprehensive income (loss), net of tax, attributable to parent33  (18)(19)53(0)
Comprehensive income, net of tax, attributable to parent:2,1492,4381,212874592402424

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: